Product
3HP
1 clinical trial
2 indications
Indication
TuberculosisIndication
HIVClinical trial
Safety, Tolerability and Drug-drug Interactions of Short-course Treatment of Latent Tuberculosis Infection With High-dose Once-weekly Rifapentine and Isoniazid (3HP) Among Infants, Children and Adolescents Living With HIV Taking Dolutegravir-based Antiretroviral TreatmentStatus: Recruiting, Estimated PCD: 2024-12-01